Robert Robles

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial

Miguel Ángel Martínez‐González, Pilar Buil‐Cosiales, Dolores Corella et al. · International Journal of Epidemiology · 2018 · 327 citations · Full text

Medicine, Health Promotion, Nutrition +17

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma

John P. Leonard, Kathryn S. Kolibaba, James A. Reeves et al. · Journal of Clinical Oncology · 2017 · 189 citations

Medicine, Hematology, Oncology +17

A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells.

G K Scott, Robert Robles, J W Park et al. · Molecular and Cellular Biology · 1993 · 156 citations · Full text

Medicine, Cancer Biology, Oncology +13

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

Sheri Skerget, Daniel Peñaherrera, Ajai Chari et al. · Nature Genetics · 2024 · 75 citations · Full text

Medicine, Molecular Genetics, Oncology +17